Yr Athro Richard Stanton

2026

• Saud, Z. et al. 2026. Discovery of a fungal Tc toxin complex and functional mycoserpin through a novel two-by-two comparative genomics approach. Frontiers in Cellular and Infection Microbiology 16 1800461. (10.3389/fcimb.2026.1800461)
• Manuli, E. R. et al., 2026. Transmission dynamics of Oropouche virus in Latin America and the Caribbean. Nature Medicine 32 , pp.1383-1392. (10.1038/s41591-026-04221-z)
• Latham, K. A. et al., 2026. Human cytomegalovirus strain-specific differences in protein expression of type I IFN pathway proteins do not impact virus replication. Access Microbiology 8 (2)(10.1099/acmi.0.001104.v3)
• Tyrrell, V. J. et al. 2026. The coronavirus envelope is modulated by host inflammation and enriched in bioactive lipids required for replication. (10.1101/2025.11.03.686211)

2025

• Connors, M. R. et al., 2025. Specificity and functional humoral immune responses induced by the VBI-1501A eVLP HCMV gB vaccine compared to the gB/MF59 vaccine. Human Vaccines & Immunotherapeutics 21 (1) 2564555. (10.1080/21645515.2025.2564555)
• Qerqez, A. N. et al., 2025. Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. Cell Reports 44 (12) 116593. (10.1016/j.celrep.2025.116593)
• Bentley, K. et al. 2025. Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. Proceedings of the National Academy of Sciences 122 (38) e2425622122. (10.1073/pnas.2425622122)
• Preston, H. et al. 2025. Human cytomegalovirus immune evasion of natural killer cells: a virus for all seasons?. Pathogens 14 (7) 629. (10.3390/pathogens14070629)
• Tam, J. C. et al., 2025. Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses. Cell Reports 44 (7) 116000. (10.1016/j.celrep.2025.116000)
• Sharma, P. et al. 2025. The pharmacokinetics of hexylresorcinol-containing lozenges and their antimicrobial efficacy against oral and respiratory microorganisms. Journal of Oral Microbiology 17 (1) 2525229. (10.1080/20002297.2025.2525229)
• Gao, Y. et al., 2025. Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology 26 , pp.692–705. (10.1038/s41590-025-02135-5)

2024

• Samer, C. et al., 2024. Impaired endocytosis and accumulation in early endosomal compartments defines herpes simplex virus–mediated disruption of the nonclassical MHC class I–related molecule MR1. Journal of Biological Chemistry 300 (10) 107748. (10.1016/j.jbc.2024.107748)
• Obergfäll, D. et al., 2024. Cyclin-dependent kinase 8 represents a positive regulator of cytomegalovirus replication and a novel host target for antiviral strategies. Pharmaceutics 16 (9) 1238. (10.3390/pharmaceutics16091238)
• Bliss, C. M. et al. 2024. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications. Molecular Therapy - Methods and Clinical Development 32 (3) 101308. (10.1016/j.omtm.2024.101308)
• Bliss, C. M. et al. 2024. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications. Molecular Therapy Advances 32 (3) 101308. (10.1016/j.omtm.2024.101308)
• Litvin, U. et al., 2024. Evolution of the cytomegalovirus RL11 gene family in old world monkeys and great apes. Virus Evolution 10 (1) veae066. (10.1093/ve/veae066)
• Amratia, P. S. et al. 2024. Cytomegalovirus-induced peroxynitrite promotes virus entry and contributes to pathogenesis in a murine model of infection. mBio 15 (8) e03152-23. (10.1128/mbio.03152-23)
• Wesgate, R. et al. 2024. Impact of artificial accelerated ageing of PVC surfaces and surface degradation on disinfectant efficacy. Journal of Hospital Infection 149 , pp.1-13. (10.1016/j.jhin.2023.12.021)
• Finkel, Y. et al., 2024. A virally encoded high-resolution screen of cytomegalovirus dependencies. Nature 630 , pp.712-719. (10.1038/s41586-024-07503-z)
• Hunter, L. M. et al., 2024. HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L. Journal of General Virology 105 (4) 001980. (10.1099/jgv.0.001980)
• Li, H. et al., 2024. Human cytomegalovirus degrades DMXL1 to inhibit autophagy, lysosomal acidification, and viral assembly. Cell Host & Microbe 32 (4), pp.466-478. E11. (10.1016/j.chom.2024.02.013)
• Samer, C. et al., 2024. Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection. iScience 27 (2) 108801. (10.1016/j.isci.2024.108801)
• Hulin-Curtis, S. et al., 2024. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. Cell Reports 43 (6) 114259. (10.1016/j.celrep.2024.114259)

2023

• Chowdhury, S. et al., 2023. Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors. Journal of General Virology 104 (12) 001929. (10.1099/jgv.0.001929)
• Vlachava, V. et al. 2023. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation. Proceedings of the National Academy of Sciences 120 (49) e2309077120. (10.1073/pnas.2309077120)
• Nan, X. et al. 2023. VarLOCK: sequencing-independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance. Scientific Reports 13 (1) 20832. (10.1038/s41598-023-47289-0)
• Duggan, K. et al. 2023. Evaluating the antimicrobial efficacy of long-lasting hand sanitisers on skin. Journal of Hospital Infection (10.1016/j.jhin.2023.08.020)
• Rubina, A. et al. 2023. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences 120 (33) e2303155120. (10.1073/pnas.2303155120)
• Grant, M. D. et al., 2023. Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2. JCI Insight 8 (15) e170681. (10.1172/jci.insight.170681)
• Semmes, E. C. et al., 2023. ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission. JCI Insight 8 (13) e167768. (10.1172/jci.insight.167768)
• Meredith, R. T. et al. 2023. Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations. Frontiers in Cellular and Infection Microbiology 13 (10.3389/fcimb.2023.1207313)
• Lista, M. J. et al., 2023. Strain-dependent restriction of human cytomegalovirus by zinc finger antiviral proteins. Journal of Virology 97 (3) e01846-22. (10.1128/jvi.01846-22)
• Ashley, C. L. et al., 2023. Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation. Frontiers in Immunology 14 (10.3389/fimmu.2023.1107497)

2022

• Dangi, T. et al., 2022. Improved control of SARS-CoV-2 by treatment with nucleocapsid-specific monoclonal antibody. Journal of Clinical Investigation 132 (23) e162282. (10.1172/JCI162282)
• Saud, Z. et al. 2022. Anti-viral organic coatings for high touch surfaces based on smart-release, Cu2+ containing pigments. Progress in Organic Coatings 172 107135. (10.1016/j.porgcoat.2022.107135)
• Scurr, M. J. et al. 2022. Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity. Nature Communications 13 5422. (10.1038/s41467-022-32985-8)
• Statkute, E. , Wang, E. and Stanton, R. 2022. An optimised CRISPR/Cas9 adenovirus vector (AdZ-CRISPR) for high throughput cloning of sgRNA, using enhanced sgRNA and Cas9 variants. Human Gene Therapy 33 (17-18), pp.990-1001. (10.1089/hum.2021.120)
• Crozier, T. W. et al., 2022. Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion. Wellcome Open Research 7 224. (10.12688/wellcomeopenres.17946.1)
• Clement, M. et al. 2022. IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses. Nature Communications 13 (1) 5294. (10.1038/s41467-022-32587-4)
• Weiler, N. et al., 2022. Combined knockdown of RL13 and UL128 for release of cell-free infectivity from recent HCMV isolates. Journal of Virological Methods 305 114537. (10.1016/j.jviromet.2022.114537)
• Saud, Z. et al. 2022. Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract. Clinical Infectious Diseases 75 (1), pp.e82-e88. ciac170. (10.1093/cid/ciac170)
• Saud, Z. et al. 2022. The SARS-CoV2 envelope differs from host cells, exposes pro-coagulant lipids, and is disrupted in vivo by oral rinses. Journal of Lipid Research 63 (6) 100208. (10.1016/j.jlr.2022.100208)
• Fielding, C. A. et al. 2022. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. eLife 11 (10.7554/eLife.74489)
• Tizaoui, C. et al., 2022. Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media. Journal of Hazardous Materials 428 128251. (10.1016/j.jhazmat.2022.128251)
• Wang, E. C. , Fielding, C. A. and Stanton, R. J. 2022. Concerns over functional experiments, interpretation, and required controls. Journal of Clinical Investigation 132 (5) e157369. (10.1172/JCI157369)
• Nightingale, K. et al., 2022. Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex. Proceedings of the National Academy of Sciences 119 (6) e2108173119. (10.1073/pnas.2108173119)
• Nan, X. et al., 2022. VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance. [Online].medRxix: (10.1101/2022.01.06.21268555)Available at: https://www.medrxiv.org/content/10.1101/2022.01.06.21268555v1.

2021

• Bentley, K. and Stanton, R. J. 2021. Hydroxypropyl methylcellulose-based nasal sprays effectively inhibit in vitro SARS-CoV-2 infection and spread. Viruses 13 (12) 2345. (10.3390/v13122345)
• Hyde, K. et al., 2021. Limited replication of human cytomegalovirus in a trophoblast cell line. Journal of General Virology 102 (11) 1683. (10.1099/jgv.0.001683)
• Lau, B. et al., 2021. Human cytomegalovirus RNA2.7 is required for upregulating multiple cellular genes to promote cell motility and viral spread late in lytic infection. Journal of Virology 95 (20) e00698-21. (10.1128/JVI.00698-21)
• Wickenhagen, A. et al., 2021. A prenylated dsRNA sensor protects against severe COVID-19. Science 374 (6567), pp.535-536. (10.1126/science.abj3624)
• Braun, B. et al., 2021. Peptide derivatives of platelet-derived growth factor receptor alpha inhibit cell-associated spread of human cytomegalovirus. Viruses 13 (9) 1780. (10.3390/v13091780)
• Clement, M. et al. 2021. IFITM3 regulates virus-induced inflammatory cytokine production by titrating Nogo-B orchestration of TLR responses. Biorxiv
• Weiler, N. et al., 2021. Role of envelope glycoprotein complexes in cell-associated spread of human cytomegalovirus. Viruses 13 (4) 614. (10.3390/v13040614)
• Vlachava, V. et al. 2021. Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus. Journal of Clinical Investigation 131 (4) e139296. (10.1172/JCI139296)

2020

• Fletcher-Etherington, A. et al., 2020. Human cytomegalovirus protein pUL36: a dual cell death pathway inhibitor. Proceedings of the National Academy of Sciences 117 (31), pp.18771 - 18779. (10.1073/pnas.2001887117)
• Lau, B. et al., 2020. Human Cytomegalovirus long non-coding RNA1.2 suppresses extracellular release of the pro-inflammatory Cytokine IL-6 by blocking NF-κB activation. Frontiers in Cellular and Infection Microbiology 10 361. (10.3389/fcimb.2020.00361)
• Houldcroft, C. J. et al., 2020. Assessing anti-HCMV cell mediated immune responses in transplant recipients and healthy controls using a novel functional assay. Frontiers in Cellular and Infection Microbiology 10 275. (10.3389/fcimb.2020.00275)
• O'Donnell, V. B. et al. 2020. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function 1 (1) zqaa002. (10.1093/function/zqaa002)
• Scurr, M. J. et al. 2020. Cancer antigen discovery is enabled by RNA-sequencing of highly purified malignant and non-malignant cells. Clinical Cancer Research (10.1158/1078-0432.CCR-19-3087)
• Elasifer, H. et al. 2020. Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8+ T-cell evasion. Journal of General Virology 101 , pp.863-872. (10.1099/jgv.0.001417)
• Taher, H. et al., 2020. In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome. PLoS Pathogens 16 (11) e1008666. (10.1371/journal.ppat.1008666)

2019

• Nobre, L. V. et al., 2019. Human cytomegalovirus interactome analysis identifies degradation hubs, domain associations and viral protein functions. eLife 8 e49894. (10.7554/eLife.49894)

2018

• Patel, M. et al. 2018. HCMV-encoded NK modulators: Lessons from in vitro and in vivo genetic variation. Frontiers in Immunology 9 2214. (10.3389/fimmu.2018.02214)
• Falk, J. et al., 2018. Large-scale screening of HCMV-seropositive blood donors indicates that HCMV effectively escapes from antibodies by cell-associated spread. Viruses 10 (9) 500. (10.3390/v10090500)
• Nightingale, K. et al., 2018. High-definition analysis of host protein stability during human cytomegalovirus infection reveals antiviral factors and viral evasion mechanisms. Cell Host and Microbe 24 (3), pp.447-460.e11. (10.1016/j.chom.2018.07.011)
• Zhang, L. et al., 2018. Expression levels of glycoprotein O (gO) vary between strains of human cytomegalovirus, influencing the assembly of gH/gL complexes and virion infectivity. Journal of Virology 92 (15) e00606-18. (10.1128/JVI.00606-18)
• Wang, E. C. Y. et al. 2018. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses. Proceedings of the National Academy of Sciences 115 (19), pp.4998-5003. (10.1073/pnas.1720950115)

2017

• Murrell, I. et al. 2017. The pentameric complex drives immunologically covert cell -cell transmission of wild-type human cytomegalovirus. Proceedings of the National Academy of Sciences 114 (23), pp.6104-6109. (10.1073/pnas.1704809114)
• Fielding, C. A. et al. 2017. Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. eLife 6 e22206. (10.7554/eLife.22206)

2016

• Assaifan, A. K. et al., 2016. Nanotextured surface on flexographic printed ZnO thin films for low-cost non-Faradaic biosensors. ACS Applied Materials & Interfaces 8 (49), pp.33802-33810. (10.1021/acsami.6b11640)
• Laib Sampaio, K. et al., 2016. The contribution of pUL74 to growth of human cytomegalovirus is masked in the presence of RL13 and UL128 expression. Journal of General Virology 97 , pp.1917-1927. (10.1099/jgv.0.000475)
• Murrell, I. et al. 2016. Genetic stability of BAC-deerived human cytomegalovirus during culture in vitro. Journal of Virology 90 (8), pp.3929-3943. (10.1128/JVI.02858-15)
• Karniely, S. et al., 2016. Human cytomegalovirus infection upregulates the mitochondrial transcription and translation machineries. mBio 7 (2) e00029-16. (10.1128/mBio.00029-16)
• Chen, K. C. et al., 2016. Leukocyte Immunoglobulin-Like Receptor 1- expressing human natural killer cell subsets differentially recognize isolates of human cytomegalovirus through the viral MHC Class I homolog UL18. Journal of Virology 90 (6), pp.3123-3137. (10.1128/JVI.02614-15)

2015

• Uusi-Kerttula, H. et al. 2015. Incorporation of peptides targeting EGFR and FGFR1 into the adenoviral fibre knob domain, and their evaluation as targeted cancer therapies. Human Gene Therapy 26 (5), pp.320-329. (10.1089/hum.2015.015)
• Hsu, J. et al., 2015. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathogens 11 (4) e1004811. (10.1371/journal.ppat.1004811)
• Stack, G. et al. 2015. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathogens 11 (2) e1004641. (10.1371/journal.ppat.1004641)
• Wilkinson, G. W. G. et al. 2015. Human cytomegalovirus: taking the strain. Medical Microbiology and Immunology 204 (3), pp.273-284. (10.1007/s00430-015-0411-4)

2014

• Stanton, R. J. et al. 2014. HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. Cell Host and Microbe 16 (2), pp.201-214. (10.1016/j.chom.2014.07.005)
• Weekes, M. et al., 2014. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157 (6), pp.1460-1472. (10.1016/j.cell.2014.04.028)
• Fielding, C. A. et al. 2014. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathogens 10 (5) e1004058. (10.1371/journal.ppat.1004058)
• Gabaev, I. et al., 2014. Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells. Journal of Virology 88 (24), pp.14326-14339. (10.1128/JVI.01691-14)

2013

• Aicheler, R. et al. 2013. Potential for natural killer cell-mediated antibody-dependent cellular cytotoxicity for control of human cytomegalovirus. Antibodies 2 (4), pp.617-635. (10.3390/antib2040617)
• Aicheler, R. J. and Stanton, R. J. 2013. Functional NK cell cytotoxicity assays against virus infected cells. In: Bailer, S. M. and Lieber, D. eds. Virus-Host Interactions. Vol. 1064, Methods in Molecular Biology Springer. , pp.275-287. (10.1007/978-1-62703-601-6_20)
• Smith, W. et al., 2013. Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host & Microbe 13 (3), pp.324-335. (10.1016/j.chom.2013.02.003)
• Murrell, I. et al. 2013. Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells. Journal of Virology 87 (19), pp.10489-10500. (10.1128/JVI.01546-13)

2012

• Prod'homme, V. et al. 2012. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. The Journal of Immunology 188 (6), pp.2794-2804. (10.4049/jimmunol.1102068)
• Fielding, C. A. et al. 2012. A novel human cytomegalovirus gene function targets the natural killer cell activating ligand MICA for lysosomal degradation [Abstract]. Immunology 137 (S1), pp.154. (10.1111/imm.12001)

2011

• Gabaev, I. et al., 2011. The human cytomegalovirus ul11 protein interacts with the receptor tyrosine phosphatase cd45, resulting in functional paralysis of t cells. PLoS Pathogens 7 (12) e1002432. (10.1371/journal.ppat.1002432)

2010

• Stanton, R. J. et al. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. Journal of Clinical Investigation 120 (9), pp.3191-3208. (10.1172/JCI42955)
• Dargan, D. J. et al., 2010. Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. Journal of General Virology 91 (6), pp.1535-1546. (10.1099/vir.0.018994-0)
• Prod'homme, V. et al. 2010. Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. Journal of General Virology 91 (8), pp.2034-2039. (10.1099/vir.0.021931-0)

2008

• Stanton, R. J. et al. 2008. Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques 45 (6), pp.659-668.
• McSharry, B. P. et al. 2008. Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. Journal of Virology 82 (9), pp.4585-4594. (10.1128/JVI.02251-07)
• Wilkinson, G. W. G. et al. 2008. Modulation of natural killer cells by human cytomegalovirus. Journal of Clinical Virology 41 (3), pp.206-212. (10.1016/j.jcv.2007.10.027)

2007

• Stanton, R. J. et al. 2007. Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. Journal of Virology 81 (15), pp.7860-7872. (10.1128/JVI.02247-06)
• Prod'homme, V. et al. 2007. The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1- NK Cells. The Journal of Immunology 178 (7), pp.4473-4481.
• Tomasec, P. et al. 2007. Adenovirus vector delivery stimulates natural killer cell recognition. Journal of General Virology 88 (4), pp.1103-1108. (10.1099/vir.0.82685-0)

2005

• Stanton, R. J. et al. 2005. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. Journal of Medical Virology 75 (1), pp.42-46. (10.1002/jmv.20235)

2003

• Stanton, R. J. , Wilkinson, G. W. G. and Fox, J. D. 2003. Analysis of human herpesvirus-6 IE1 sequence variation in clinical samples. Journal of Medical Virology 71 (4), pp.578-584. (10.1002/jmv.10508)